20.52
0.72%
-0.245
Finanzdaten der Dianthus Therapeutics Inc-Aktie (DNTH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-09-30 |
Periodenlänge | 3 Monate | 3 Monate |
Revenues |
5.41%
0.874
|
0.924 |
Operating Expenses
|
12.20%
18.72
|
16.68 |
Benefits Costs and Expenses |
14.62
|
- |
Costs And Expenses |
12.20%
18.72
|
16.68 |
Operating Income/Loss |
13.23%
-17.84
|
-15.76 |
Nonoperating Income/Loss |
311.24%
4.096
|
0.996 |
Income/Loss From Continuing Operations Before Tax |
1,588%
-13.75
|
0.924 |
Income/Loss From Continuing Operations After Tax |
6.88%
-13.75
|
-14.76 |
Net Income/Loss
|
6.88%
-13.75
|
-14.76 |
Preferred Stock Dividends And Other Adjustments |
-
|
- |
Attributable To Noncontrolling Interest |
-
|
- |
Basic Average Shares |
556.93%
25.67
|
3.9069 |
Diluted Average Shares |
556.93%
25.67
|
3.9069 |
Basic Earnings Per Share |
85.71%
-0.54
|
-3.78 |
Diluted Earnings Per Share |
85.71%
-0.54
|
-3.78 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):